Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices ...

Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...

The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

The alliance positions GE Healthcare to distribute Radnet software designed to help mammography centers view images, ...

Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the initiation of the EMBO-02 clinical study of NeoCast™ to treat chronic subdural ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...